Short-Term Effectiveness of a Lifestyle Intervention Program for Reducing Selected Chronic Disease Risk Factors in Individuals Living in Rural Appalachia: A Pilot Cohort Study

Table 3

(a) Changes in selected chronic disease risk factors according to initial risk classification on 225 participants of the Athens, OH, CHIP. (b) Changes in selected chronic disease risk factors according to initial risk classification on 225 participants of the Athens, OH, CHIP.

(a)  

Risk factor	𝑁	𝑁	𝜒^2∗ (𝑃)	Baseline		Post-intervention		Δ	Δ	𝑃	Cohen’s 𝑑
	Baseline	Post-intervention		Mean SD		Mean SD		Mean	%
BMI (kg/m^2)
18.5–24.9	35	51	31 (<0.001)	22.7	1.7	22.3	2.6	−0.4	−1.8%	>0.2	0.20
25–30	57	58		27.3	1.3	26.1	1.4	−1.2	−4.4%	<0.001	1.90
>30	116	99		37.6	6.4	36.2	6.2	−1.4	−3.7%	<0.001	1.51
SBP (mmHg)
<120	66	104	38 (<0.001)	111.3	8.3	113.0	10.9	1.7	1.5%	0.169	−0.17
120–139	91	78		130.3	5.6	122.7	12.1	−7.6	−5.8%	<0.001	0.64
140–160	38	19		148.8	5.6	130.4	14.4	−18.4	−12.4%	<0.001	1.29
>160	8	2		170.4	10.5	150.2	21.1	−20.2	−11.9%	0.01	1.24
DBP (mmHg)
<80	130	154	12 (<0.001)	70.8	6.6	71.9	8.3	1.1	1.6%	0.066	−0.16
80–89	54	39		85.0	3.3	78.9	8.1	−6.1	−7.2%	<0.001	0.74
>90	19	10		94.4	2.6	82.4	8.9	−12	−12.7%	<0.001	1.39
TC (mg/dL)
<160	51	108	59 (<0.001)	141.5	15.1	133.1	27.7	−8.4	−5.9%	0.009	0.38
160–199	97	63		181.2	11.7	160.8	22.1	−20.4	−11.3%	<0.001	1.02
200–239	47	35		218.3	10.8	189.2	26.7	−29.1	−13.3%	<0.001	1.07
240–280	16	7		253.2	10.0	233.2	25.1	−20	−7.9%	0.015	0.69
>280	3	1		303	29.7	216.3	55.7	−86.7	−28.6%	0.192	1.12

(b)  

Risk factor	𝑁	𝑁	𝜒^2∗ (𝑃)	Baseline		Post-intervention		Δ	Δ	𝑃	Cohen’s 𝑑
	Baseline	Post-intervention		Mean SD		Mean SD		Mean	%
LDL (mg/dL)
<100	78	115	52 (<0.001)	78.3	18.6	72.9	23.5	−5.4	−6.9%	0.114	0.18
100–129	67	56		115.0	8.2	99.5	18.3	−15.5	−13.5%	<0.001	0.86
130–159	46	33		143.1	9.8	125.7	19.8	−17.4	−12.2%	<0.001	0.94
160–190	14	6		169.4	7.0	145.6	25.1	−23.8	−14.0%	0.004	0.92
>190	5	0		210.6	19.2	141.4	29.1	−69.2	−32.9%	0.015	1.83
HDL (mg/dL)
<40	69	105	60 (<0.001)	34.9	3.7	33.4	4.6	−1.5	−4.3%	0.004	0.36
40–60	101	89		48.8	5.6	42.2	7.0	−6.6	−13.5%	<0.001	1.16
>60	44	20		72.1	13.7	62.5	15.7	−9.6	−13.3%	<0.001	0.86
TG (mg/dL)
<100	80	84	1.5 (>0.2)	71.3	19.0	81.3	32.8	10.0	14.0%	0.001	−0.38
100–199	102	103		143.7	29.7	133.5	43.5	−10.2	−7.1%	0.023	0.23
200–400	29	26		256.3	43.0	206.5	84.5	−49.8	−19.4%	0.002	0.63
>400	3	1		444.7	57.6	219.0	48.9	−225.7	−50.8%	0.019	4.16
FPG (mg/dL)
<110	162	181	15 (<0.001)	94.7	8.8	93.2	9.1	−1.5	−1.6%	0.021	0.18
110–125	27	18		116.2	4.0	108.1	11.9	−8.1	−7.0%	<0.001	0.70
>125	24	14		169.1	52.3	131.6	29.9	−37.5	−22.2%	<0.001	0.99